Here's how it looks: Five years ago, Insulet Corporation $PODD stock was around $252 per share. Today in late February 2026, it stands at $246.61—a small overall dip of about 2%. The chart reveals ups and downs, with strong rallies in some years but ending near where it started, reflecting the ups and downs in medical device demand.

The 52-week high hit $354.88, which shows the stock has had periods of much stronger performance recently.

Keeping it straightforward: The compound annual growth rate (CAGR) works out to roughly -0.4% over the five years. That's the yearly average change figured from the ending price compared to the start, raised to the power of 1/5 minus one. If this trend continues, it points to fairly stable but slightly lower values year over year.

Now think about using dollar-cost averaging (DCA) for your approach: adding $500 every month over the next five years, whatever the price does. This comes to $30,000 total invested across 60 months. The method means you get more shares on lower price days and less on higher ones, helping even out your costs.

Following the same historical path around that -0.4% annual rate, your monthly additions would see very minor changes from the growth factor. After the full five years, the total might come to about $29,700. This would mean a small difference of roughly $300 less than your contributions—an overall return close to flat.

Build your portfolio, one day at a time.
Get our daily 5-year horizon picks sent to your inbox. Subscribe here.

Of course, history does not guarantee what happens next—new products, competition in diabetes care, or broader market moves can make a difference. Yet PODD remains a key player in insulin pump technology with ongoing innovation. Your $500 monthly adds up in a simple way, giving time to work through any short-term shifts.

The push toward better diabetes management tools keeps creating steady interest in this space. Holding steady with your plan, even in quieter times, often leads to balanced outcomes over the long run.

Ready to build on this path?